Bokus

Aurora Esquela-Kerscher – författare

Visar alla böcker från författaren Aurora Esquela-Kerscher. Handla med fri frakt och snabb leverans.

3 produkter

  1. Philip V Peplow, Bridget Martinez, George A Calin, Aurora Esquela-Kerscher - MicroRNAs in Diseases and Disorders, Inbunden. Tillgänglighet: Lägg i varukorg

    MicroRNAs in Diseases and Disorders

    Emerging Therapeutic Targets

    Av Philip V Peplow, Bridget Martinez m. fl.

    Inbunden, 2019

    3357 kr

    Lägg i varukorg

    From pathology to treatment, MicroRNAs in Diseases and Disorders highlights the role of microRNAs (miRNAs) in the development and progression of a variety of diseases, including cancer, neurological disease, endocrine disease and autoimmune disease, and underscores the utilization of miRNA targets …

  2. Aurora Esquela-Kerscher, George A Calin, Bridget Martinez, Philip V Peplow - MicroRNAs in Diseases and Disorders, E-bok. Tillgänglighet: Lägg i varukorg

    MicroRNAs in Diseases and Disorders

    Emerging Therapeutic Targets

    Av Aurora Esquela-Kerscher, George A Calin m. fl.

    E-bok, 2019

    3004 kr

    Lägg i varukorg

    From pathology to treatment, MicroRNAs in Diseases and Disorders highlights the role of microRNAs (miRNAs) in the development and progression of a variety of diseases, including cancer, neurological disease, endocrine disease and autoimmune disease, and underscores the utilization of miRNA targets …

  3. Aurora Esquela-Kerscher, George A Calin, Bridget Martinez, Philip V Peplow - MicroRNAs in Diseases and Disorders, E-bok. Tillgänglighet: Lägg i varukorg

    MicroRNAs in Diseases and Disorders

    Emerging Therapeutic Targets

    Av Aurora Esquela-Kerscher, George A Calin m. fl.

    E-bok, 2019

    3004 kr

    Lägg i varukorg

    From pathology to treatment, MicroRNAs in Diseases and Disorders highlights the role of microRNAs (miRNAs) in the development and progression of a variety of diseases, including cancer, neurological disease, endocrine disease and autoimmune disease, and underscores the utilization of miRNA targets …